259 related articles for article (PubMed ID: 21802410)
1. Differential PAX3 functions in normal skin melanocytes and melanoma cells.
Medic S; Rizos H; Ziman M
Biochem Biophys Res Commun; 2011 Aug; 411(4):832-7. PubMed ID: 21802410
[TBL] [Abstract][Full Text] [Related]
2. PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas).
Medic S; Ziman M
PLoS One; 2010 Apr; 5(4):e9977. PubMed ID: 20421967
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms contributing to differential regulation of PAX3 downstream target genes in normal human epidermal melanocytes versus melanoma cells.
Bartlett D; Boyle GM; Ziman M; Medic S
PLoS One; 2015; 10(4):e0124154. PubMed ID: 25880082
[TBL] [Abstract][Full Text] [Related]
4. Human melanocytes form a PAX3-expressing melanocyte cluster on Matrigel by the cell migration process.
Choi H; Jin SH; Han MH; Lee J; Ahn S; Seong M; Choi H; Han J; Cho EG; Lee TR; Noh M
J Dermatol Sci; 2014 Oct; 76(1):60-6. PubMed ID: 25128984
[TBL] [Abstract][Full Text] [Related]
5. PAX3 across the spectrum: from melanoblast to melanoma.
Medic S; Ziman M
Crit Rev Biochem Mol Biol; 2009 Jun; 44(2-3):85-97. PubMed ID: 19401874
[TBL] [Abstract][Full Text] [Related]
6. Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease.
Kubic JD; Young KP; Plummer RS; Ludvik AE; Lang D
Pigment Cell Melanoma Res; 2008 Dec; 21(6):627-45. PubMed ID: 18983540
[TBL] [Abstract][Full Text] [Related]
7. The E3 ligase APC/C(Cdh1) promotes ubiquitylation-mediated proteolysis of PAX3 to suppress melanocyte proliferation and melanoma growth.
Cao J; Dai X; Wan L; Wang H; Zhang J; Goff PS; Sviderskaya EV; Xuan Z; Xu Z; Xu X; Hinds P; Flaherty KT; Faller DV; Goding CR; Wang Y; Wei W; Cui R
Sci Signal; 2015 Sep; 8(392):ra87. PubMed ID: 26329581
[TBL] [Abstract][Full Text] [Related]
8. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR
Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of alternative isoforms of the transcription factor PAX3 in melanocytes in vitro.
Wang Q; Kumar S; Slevin M; Kumar P
Cancer Res; 2006 Sep; 66(17):8574-80. PubMed ID: 16951170
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.
Berlin I; Denat L; Steunou AL; Puig I; Champeval D; Colombo S; Roberts K; Bonvin E; Bourgeois Y; Davidson I; Delmas V; Nieto L; Goding CR; Larue L
Mol Cell Biol; 2012 Apr; 32(7):1237-47. PubMed ID: 22290434
[TBL] [Abstract][Full Text] [Related]
11. Melanoblasts in culture as an in vitro system to determine molecular changes in melanoma.
Bosserhoff AK; Ellmann L; Kuphal S
Exp Dermatol; 2011 May; 20(5):435-40. PubMed ID: 21496114
[TBL] [Abstract][Full Text] [Related]
12. PAX3 Is extensively expressed in benign and malignant tissues of the melanocytic lineage in humans.
He S; Yoon HS; Suh BJ; Eccles MR
J Invest Dermatol; 2010 May; 130(5):1465-8. PubMed ID: 20107488
[No Abstract] [Full Text] [Related]
13. TBX2 expression is regulated by PAX3 in the melanocyte lineage.
Liu F; Cao J; Lv J; Dong L; Pier E; Xu GX; Wang RA; Xu Z; Goding C; Cui R
Pigment Cell Melanoma Res; 2013 Jan; 26(1):67-77. PubMed ID: 23020925
[TBL] [Abstract][Full Text] [Related]
14. PAX3 expression in primary melanomas and nevi.
Plummer RS; Shea CR; Nelson M; Powell SK; Freeman DM; Dan CP; Lang D
Mod Pathol; 2008 May; 21(5):525-30. PubMed ID: 18327212
[TBL] [Abstract][Full Text] [Related]
15. Pax3( GFP ) , a new reporter for the melanocyte lineage, highlights novel aspects of PAX3 expression in the skin.
Djian-Zaouche J; Campagne C; Reyes-Gomez E; Gadin-Czerw S; Bernex F; Louise A; Relaix F; Buckingham M; Panthier JJ; Aubin-Houzelstein G
Pigment Cell Melanoma Res; 2012 Sep; 25(5):545-54. PubMed ID: 22621661
[TBL] [Abstract][Full Text] [Related]
16. A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma.
Bonvin E; Falletta P; Shaw H; Delmas V; Goding CR
Mol Cell Biol; 2012 Nov; 32(22):4674-83. PubMed ID: 22988297
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta targets PAX3 to control melanocyte differentiation.
Moustakas A
Dev Cell; 2008 Dec; 15(6):797-9. PubMed ID: 19081068
[TBL] [Abstract][Full Text] [Related]
18. How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance.
Wessely A; Steeb T; Berking C; Heppt MV
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071193
[TBL] [Abstract][Full Text] [Related]
19. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
[TBL] [Abstract][Full Text] [Related]
20. Pax3 transcripts in melanoblast development.
Blake JA; Ziman MR
Dev Growth Differ; 2005 Dec; 47(9):627-35. PubMed ID: 16316407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]